Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Tirzepatide (Zepbound), a dual GLP-1/GIP receptor agonist, is also approved for weight management, though evidence in post-bariatric populations is still emerging
A point worth emphasizing: these medications are not a substitute for lifestyle work
Contact us with any questions you have to determine if Semaglutide is a good option for your weight loss journey
That includes offering no-cost care options, so you can focus on your health, instead of worrying about copays and deductibles
The SOUL trial (2025), a large-scale, double-blind, placebo-controlled study, evaluated once-daily oral semaglutide in 9,650 patients with T2DM and established atherosclerotic cardiovascular disease, chronic kidney disease, or both
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
